Hepatitis C Virus (HCV) Quasispecies Complexity and Selection in HCV/HIV-Coinfected Subjects Treated with Interferon-Based Regimens

Sherman, Kenneth E.; Rouster, Susan D.; Stanford, Sandra; Blackard, Jason T.; Shire, Norah; Koziel, Margaret; Peters, Marion; Chung, Raymond T.
March 2010
Journal of Infectious Diseases;3/1/2010, Vol. 201 Issue 5, p712
Academic Journal
Background. Coinfection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) has emerged as a major cause of morbidity and mortality due to liver disease. Interferon-based therapy response rates have been disappointingly low. Baseline HCV complexity and the relationship between complexity and viral kinetic parameters has not been well described in HCV/HIV-coinfected subjects. Methods. A subset of patients enrolled in the AIDS Clinical Trials Group 5071 trial underwent sampling to evaluate viral kinetics and changes in HCV complexity. Early kinetic parameters, baseline complexity, and treatment outcomes—including rapid viral response (RVR), early viral response (EVR), and sustained viral response (SVR)— were evaluated. HCV-monoinfected subjects were matched to HCV/HIV-coinfected subjects. Results. Baseline complexity was determined in 108 HCV/HIV-coinfected subjects and in 13 HCV-monoinfected control subjects. Quasispecies complexity was a mean of 2.24 bands for HCV/HIV-coinfected subjects and a mean of 1.90 bands for HCV-monoinfected subjects (P=.14). Lower baseline complexity was associated with EVR (P=.04) and approached statistical significance for SVR. In patients who underwent viral kinetic modeling, a decrease in complexity was associated with RVR (P=.03) and was independent of the correlation between firstphase viral decline efficiency and RVR. Conclusion. Baseline HCV complexity is an independent predictor of EVR in HCV/HIV-coinfected subjects. A decrease in complexity occurs by 4 weeks after the initiation of interferon-based therapy and is associated with RVR. These findings may enhance the predictive modeling of treatment outcome in HCV/HIV-coinfected patients.


Related Articles

  • HAART-Prolonged Life of HIV-Infected Patients Should Not Be Shortened by Hepatitis C. Horster, S.; Goebel, F.D. // Infection;Dec2004, Vol. 32 Issue 6, p369 

    As highly active antiretroviral treatment (HAART) prolongs the life of HIV-infected individuals and reduces mortality associated with opportunistic infections, liver diseases have become a major challenge in the management of these patients. Up to 45% of deaths of persons with HIV are related to...

  • A Call for Routine HIV Testing Among Patients with Hepatitis C Virus Infection. Taylor, Lynn E.; Gaitanis, Melissa M.; Beckwith, Curt G. // Open Infectious Diseases Journal;2011, Vol. 5, p97 

    The authors discuss aspects of routine HIV testing among patients infected with hepatitis C virus. They refer to studies that found overly high HIV prevalence in HCV-infected patients and high threshold prevalence of undiagnosed HIV infection due to inadequate routine testing. The authors...

  • GB Virus C (GBV-C) Infection in Hepatitis C Virus (HCV) Seropositive Women with or at Risk for HIV Infection. Blackard, Jason T.; Ma, Gang; Welge, Jeffrey A.; King, Caroline C.; Taylor, Lynn E.; Mayer, Kenneth H.; Klein, Robert S.; Celentano, David D.; Sobel, Jack D.; Jamieson, Denise J.; Gardner, Lytt // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    Background: GB virus C (GBV-C) may have a beneficial impact on HIV disease progression; however, the epidemiologic characteristics of this virus are not well characterized. Behavioral factors and gender may lead to differential rates of GBV-C infection; yet, studies have rarely addressed GBV-C...

  • Virological response reduces mortality in HIV/hepatitis C coinfection. Levitan, Dave // Infectious Disease News;Apr2008, Vol. 21 Issue 4, p28 

    The article discusses research on the association between sustained virological response (SVR) to interferon plus ribavirin and reduction in liver-related complications and mortality in patients coinfected with HIV and hepatitis C virus. It references a study by J. Berenguer et al, presented at...

  • Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus--Infected Patients with Chronic Hepatitis C: A European Collaborative Study. Mart&iacuate;n-Carbonero, Luz; Benhamou, Yves; Puoti, Massimo; Berenguer, Juan; Mallolas, José; Quereda, Carmen; Arizcorreta, Ana; Gonzalez, Antonio; Rockstroh, Jurgen; Asensi, Victor; Miralles, Pilar; Laguno, Montse; Moreno, Leonor; Girón, José Antonio; Vogel, Martin; García-Samaniego, Javier; Nuñez, Marina; Romero, Miriam; Moreno, Santiago; de Ia Cruz, Juan José // Clinical Infectious Diseases;1/1/2004, Vol. 38 Issue 1, p128 

    A study was performed in 10 European health care centers in which 914 patients coinfected with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) who had elevated serum alanine aminotransferase (ALT) levels underwent liver biopsy during the period of 1992 through 2002. Overall, the...

  • Pegylated Interferon and Ribavirin Promote Early Evolution of Nonstructural 5A Protein in Individuals with Hepatitis C Who Demonstrate a Response to Treatment. Jain, Mamta K.; He-Jun Yuan; Adams-Huet, Beverley; Reeck, Amanda; Shelton, Janel; Attar, Nahid; Song Zhang; Neumann, Avidan U.; Carney, David S.; Gale, Jr., Michael; William M. Lee // Journal of Infectious Diseases;9/15/2009, Vol. 200 Issue 6, p866 

    Background. Hepatitis C virus (HCV) quasispecies diversity is more likely to affect early viral decline during treatment of hepatitis C than is having human immunodeficiency virus (HIV) infection.We evaluated the influence of HCV therapy on changes in the nonstructural 5A (NS5A) protein....

  • Incidence and Predictors of Severe Liver Fibrosis in HIV-Infected Patients with Chronic Hepatitis C in Brazil. Mendes-Correa, Maria Cássia; Widman, Azzo; Brussi, Maria Luiza Paes; Guastini, Cristina Fátima; Gianini, Reinaldo Jos // AIDS Patient Care & STDs;Sep2008, Vol. 22 Issue 9, p701 

    The aim of this study was to examine the incidence and factors associated with the severity of liver fibrosis in 234 coinfected patients in Brazil. Patients were cared for in our clinic, from 1996 to 2004. Eligible patients were defined as patients with documented HIV and hepatitis C virus (HCV)...

  • Evidence of Recombination in Intrapatient Populations of Hepatitis C Virus. Sentandreu, Vicente; Jiménez-Hernández, Nuria; Torres-Puente, Manuela; Bracho, María Alma; Valero, Ana; Gosalbes, María José; Ortega, Enrique; Moya, Andrés; González-Candelas, Fernando // PLoS ONE;2008, Vol. 3 Issue 9, p1 

    Hepatitis C virus (HCV) is a major cause of liver disease worldwide and a potential cause of substantial morbidity and mortality in the future. HCV is characterized by a high level of genetic heterogeneity. Although homologous recombination has been demonstrated in many members of the family...

  • PRO-C3-Levels in Patients with HIV/HCV-Co-Infection Reflect Fibrosis Stage and Degree of Portal Hypertension. Jansen, Christian; Leeming, Diana J.; Mandorfer, Mattias; Byrjalsen, Inger; Schierwagen, Robert; Schwabl, Philipp; Karsdal, Morten A.; Anadol, Evrim; Strassburg, Christian P.; Rockstroh, Jürgen; Peck-Radosavljevic, Markus; Møller, Søren; Bendtsen, Flemming; Krag, Aleksander; Reiberger, Thomas; Trebicka, Jonel // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Background: Liver-related deaths represent the leading cause of mortality among patients with HIV/HCV-co-infection, and are mainly related to complications of fibrosis and portal hypertension. In this study, we aimed to evaluate the structural changes by the assessment of extracellular matrix...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics